Angiogenesis is essential to match the size of blood vessel networks to the metabolic demands of growing tissues. While many genes and pathways necessary for regulating angiogenesis have been identified, those responsible for endothelial cell (EC) survival during angiogenesis remain largely unknown. We have investigated the in vivo role of myeloid cell leukemia 1 (MCL1), a pro-survival member of the BCL2 family, in EC survival during angiogenesis. EC-specific deletion of Mcl1 resulted in a dosedependent increase in EC apoptosis in the angiogenic vasculature and a corresponding decline in vessel density. Our results suggest this apoptosis was independent of the BH3-only protein BIM. Despite the known link between apoptosis and blood vessel regression, this was not the cause of reduced vessel density observed in the absence of endothelial MCL1. Rather, the reduction in vessel density was linked to ectopic apoptosis in regions of the angiogenic vasculature where EC proliferation and new vessel growth occurs. We have therefore identified MCL1 as an essential survival factor for ECs that is required for blood vessel production during angiogenesis.
vaso-obliteration of immature retinal vessels in response to hyperoxia 13 and apoptosis of tumor-associated ECs following VEGF-A blockade. 6 While it is clear the BCL2-mediated apoptosis pathway is responsible for EC death, little is known about which pro-survival proteins of this pathway normally promote EC survival through apoptosis suppression. Here, we demonstrate that the pro-survival protein MCL1 is essential for the survival of ECs undergoing angiogenesis in vivo, particularly those ECs located in the proliferative regions of the angiogenic network.
Results

MCL1 is essential for EC development. Germline loss of
Mcl1 results in peri-implantation lethality. 14 To investigate the role of MCL1 in EC development, we deleted Mcl1 by crossing a Tie2-cre transgene (which is active in ECs and their progenitors from embryonic day (E)7.5 (ref. 15)), with a conditional Mcl1 allele in which an human cluster of differentiation 4 (hCD4) reporter is expressed from the Mcl1 locus on cre-mediated excision. 16 These mice will hereafter be referred to as Mcl1
EC . Flow cytometric analysis of hCD4 reporter expression in the embryo proper and yolk sac of E10.5 embryos showed a dose-dependent shift in hCD4 expression on ECs from Mcl1 EC/+ and Mcl1 EC/EC embryos, demonstrating efficient deletion of the Mcl1 allele ( Figure 1a ). The Mcl1 EC/EC embryos were present at the expected Mendelian ratios at E10.5 (Table 1) , however, fewer mutants were observed at E14.5, with the majority of those that were present showing one or a combination of edema, hemorrhage or presumed blood-filled lymphatics ( Figure 1b , Table 1 ). Several Mcl1 EC/EC embryos at E14.5 lacked heartbeat or were undergoing resorption. This indicated embryonic lethality was occurring at or prior to E14.5.
Mcl1 EC/EC mutants were significantly under-represented at weaning (P = 0.001, χ 2 -test) (Table 1) , however, a small number did survive to adulthood. While hCD4 expression was present on ECs from the kidney, lung and skeletal muscle in adult Mcl1 EC/+ mice, hCD4 was not detected on ECs from the few surviving Mcl1 EC/EC mice (Figure 1c ), and the deleted (Δ) Mcl1 allele was extremely low or undetectable by genomic PCR in ECs sorted from those few adult Mcl1 EC/EC mice (n = 3) (Figure 1d ). This demonstrates that ECs in the surviving Mcl1 EC/EC mice had escaped cre-mediated Mcl1 deletion. Consistent with this, we noted that hCD4 expression in ECs at E10.5 was bimodal in approximately one in seven embryos (combined Mcl1 EC/+ and Mcl1 EC/EC embryos) ( Figure 1e ). Given hCD4 expression was observed uniformly in ECs from four out of five Mcl1 EC/EC embryos at E10.5, bimodal presentation of hCD4 was not likely a result of EC death due to reduced MCL1, but was more likely due to cre inefficiency prior to E10.5. Such cre inefficiency in Mcl1 EC/EC mice would result in a proportion of ECs in which Mcl1 was not deleted, enabling them to out-compete Mcl1-deficient cells and permit formation of a normal vasculature and survival into adulthood.
Embryonic angiogenesis is disrupted in the absence of MCL1. To determine the effect of MCL1 loss on angiogenesis, we investigated the development of the subcutaneous vasculature in dorsal skin in embryos at E14.5. Blood vessels emerge laterally then migrate toward the dorsal midline to fully cover the dorsal skin between E14.5 and E15.5. 17 Given the variability of Mcl1 deletion we observed in the Mcl1 EC/EC embryos, we analyzed only those embryos with evidence of edema as a means to select embryos with the highest likelihood of efficient cre-mediated excision of the Mcl1 allele. Vascularization of the dorsal skin was delayed in Mcl1 EC/EC embryos, with an increased avascular area present at the midline of E14.5 embryos (Figure 1f) . Furthermore, vessel sprouts at the leading edge of the growing vasculature in Mcl1 EC/EC embryos were elongated, with fewer side branches (Figure 1g ). Attempts to quantify EC apoptosis were complicated by an inability to clearly determine whether apoptotic cells were endothelial or hematopoietic cells (in which Tie2-cre is also active 15 ) and excessive autofluorescence from circulating and extravasated erythrocytes (due to hemorrhage). These data indicate that angiogenesis was abnormal in embryos lacking endothelial MCL1, however, to what extent this was due to a cell-autonomous survival defect or a response to stretching of the dorsal skin by the underlying edema was unclear.
MCL1 is a dose-dependent survival factor for angiogenic endothelium. To investigate the consequences of Mcl1 loss on EC survival in greater detail, we crossed the Mcl1 conditional allele with the tamoxifen-inducible, EC-specific Cdh5(PAC)-creERT2 transgene 18 and induced Mcl1 deletion in neonates. These mice are hereafter referred to as Mcl1 iEC mice. ECs of the kidney and skeletal muscle from postnatal day (P) 5 pups showed efficient cre-mediated deletion of the Mcl1 allele following tamoxifen administration based on hCD4 expression (Figure 2a ). Mcl1 iEC mice showed no expression of the hCD4 on CD45 + Ter119 − white blood cells in the bone marrow, confirming the specificity of the inducible cre for ECs and not hematopoietic cells (Figure 2a) . To determine the effect of inducible Mcl1 deletion on angiogenesis, we examined retinal vasculature in Mcl1 iEC/iEC pups following tamoxifen administration. Quantification of the retinal vascular density at P5 revealed a gene-dosage-dependent effect of Mcl1 loss on vascular density, with Mcl1 iEC/iEC retinas containing significantly less vessel surface area, vessel segments and vessel branch points than controls (Figures 2b and c) . Given MCL1 is a pro-survival protein, EC apoptosis was assessed at P5 by staining for platelet/ endothelial cell adhesion molecule 1 (PECAM1), collagen IV and cleaved (activated) caspase-3 ( Figure 3a) . Apoptotic ECs were quantified across the whole vasculature of mutant and control retinas by confocal imaging. Mcl1 iEC/+ and Mcl1 iEC/iEC pups contained significantly more apoptotic ECs than controls (Figure 3b ), and demonstrated a gene-dosagedependent effect on EC survival.
Reduced vessel density in Mcl1 mutants is not due to increased blood vessel regression. We examined whether the reduction in vasculature in MCL1 mutants was caused by increased vessel regression, a common consequence of EC apoptosis. 5, 10, 19, 20 We quantified vessel regression in mutant and control retinas based on the presence of collagen IV sleeves devoid of PECAM1 signal, which mark sites of vessel regression 21, 22 ( Figure 3c ). Vessel regression was quantified in the region of the remodeling vein and in the sprouting region as these were sites of significantly increased apoptosis in the mutants (see below), but we saw no difference in the amount of vessel regression in either location irrespective of genotype (Figures 3d and e) . Increased vessel regression was therefore unlikely to explain the reduced vasculature observed in the MCL1 mutants.
MCL1 prevents EC apoptosis in proliferative and sprouting regions of the angiogenic vessel network. Having excluded vessel regression, we investigated whether the distribution of apoptotic ECs could account for the reduced vascularization of mutant retinas. We quantified the number of apoptotic ECs within the sprouting zone (area external to red circles in Figure 4a ), and their proximity to maturing arteries and veins within the remodeling zone (area within red circles in Figure 4a ). Apoptotic ECs in P5 control retinas were predominantly located around the developing arteries, with few seen in the venous or sprouting territories (Figures 4a  and b) . Relative to controls, EC apoptosis in mutant retinas was only marginally increased (1.5-fold) around arteries, which was not significant. In contrast, EC apoptosis in both Mcl1 iEC/+ and Mcl1 iEC/iEC retinas was significantly increased around veins in the remodeling zone (Figures 4a and b) and in the sprouting zone of Mcl1 iEC/iEC mice, regions in which EC proliferation and new vessel sprouting occurs. 8, 9 Notably, homozygote mutants had significantly more apoptotic cells than heterozygotes in both these areas. These results demonstrate that MCL1 is required for the survival of ECs located in those regions of the vasculature necessary for new vessel production.
BIM is not required for EC apoptosis or reduced vascular density caused by the loss of MCL1. In addition to its prosurvival role, MCL1 has been show to regulate mitochondrial fusion, cristae morphology and ATP generation through oxidative phosphorylation. 23 We therefore sought to determine the extent to which the ectopic EC apoptosis observed in the Mcl1 mutants was responsible for the angiogenic phenotype. Given BIM is responsible for retina EC apoptosis in vivo, 4 (Figure 5c ). These results suggest that EC apoptosis following the loss of MCL1 proceeds independently of BIM.
Simultaneous deletion of Bak and Bax rescues the EC apoptosis defect, embryonic lethality and angiogenesis defects in Tie2-cre-deleted Mcl1 mutants. As deletion of Bim was insufficient to rescue the phenotype of the Mcl1 mutants, we generated mice in which both of the intrinsic apoptosis effectors, Bak and Bax, were deleted specifically in the endothelium using Tie2-cre. Triple mutant mice lacking iEC/+ (n = 5, gray circles) and Mcl1 iEC/iEC (n = 6, closed circles) pups at P5. Vessel surface area was measured based on collagen IV + signal. Branch point density and segment density were quantified on skeletonized collagen IV signal and normalized to total area from two fields of view per retina. Data from six litters. Mean ± S.E.M. Not significant (NS): P40.05; *P ⩽ 0.05, one-way ANOVA with Tukey's post hoc multiple comparison test (Figure 6c ). While the number of triple mutants analyzed at P5 was small (n = 2), these data strongly suggest that the Mcl1 angiogenesis phenotype is due to compromised EC survival.
Discussion
EC apoptosis is dependent on members of the BCL2 pathway. While the requirement for pro-apoptotic pathway members is well-defined, the identity of those that promote EC survival in vivo is largely unknown. Here we have shown that MCL1 is essential for EC survival during angiogenesis in vivo.
The loss of endothelial MCL1 during embryonic stages resulted in hemorrhage, edema and embryonic lethality. However, given the Tie2-cre transgene used to delete Mcl1 also causes deletion in hematopoietic cells 15 and MCL1 is required for the survival of hematopoietic stem cells, 24 it seems likely that hematopoietic defects will contribute to the embryonic lethality of Mcl1 EC/EC mutants, making the EC-specific role of MCL1 in the survival of these animals difficult to discern. Our use of the inducible Cdh5(PAC)-creERT2 transgene, which we showed was not active in hematopoietic cells in neonates, confirms that MCL1 is essential for EC survival in a cell-autonomous manner during postnatal angiogenesis.
Our results show that during angiogenesis, MCL1 is a key survival factor for ECs in the proliferative regions of the angiogenic vasculature, and its role in angiogenesis is to promote new vessel production rather than to prevent inappropriate vessel regression. It is not possible to conclude from our data whether MCL1 is required for the survival of ECs that are actively proliferating, or whether its loss simply limits the number of cells available to proliferate and generate new vessels. Several stimuli have been reported to promote EC apoptosis through downregulation of MCL1 in vitro. These include hypoxia, 25, 26 suppression of ERK 27 and Rho inhibition. 28 Conversely, the S1P receptor agonist FTY720P was reported to delay apoptosis in serum-starved HUVEC by upregulating MCL1. 29 How MCL1 activity is directed to the proliferative regions of the angiogenic network in vivo will be an important question to address.
BIM is required for EC apoptosis in the angiogenic retina, 4, 13 and forms endogenous complexes with MCL1 in ECs. 27 However, Bim deletion was not sufficient to rescue the apoptosis defect caused by the loss of Mcl1 in the limited number of mice studied here. While the small number of T/+ double mutant animals analyzed prevents conclusive interpretation, the data suggest that BIM is not essential for EC apoptosis to proceed following loss of MCL1, and that BIM is not the major antagonist of MCL1 in this system. This result is consistent with findings in the hematopoietic system, where PUMA, not BIM, is the dominant antagonist of MCL1. 30 In ECs however, PUMA has been reported to promote EC survival during angiogenesis. 31 MCL1 also binds the BH3-only proteins BID and noxa, 11 but the roles of these proteins in promoting EC apoptosis following MCL1 loss is yet to be determined. However, simultaneous deletion of both Bak and Bax was sufficient to overcome the Mcl1 vascular phenotype. While the number of mice analyzed was small and prevent conclusive interpretation, the data strongly suggest that the requirement for MCL1 in angiogenic ECs is primarily due to its pro-survival role, rather than a defect in oxidative phosphorylation as reported in other cell types. 23, 32 This is consistent with findings that ECs rely predominantly on glycolysis for energy production, and that this further increases in response to pro-angiogenic signals such as VEGF-A. 33 Our analysis of the distribution of apoptotic ECs in nonmutant control mice confirms the results of others that suggest EC apoptosis is associated with arterial vessel pruning. 10 However, our observations in the Mcl1 mutant mice show that EC apoptosis does not always cause vessel regression, as has been suggested from other mutant phenotypes. 10, 34, 35 This raises the question of whether EC apoptosis is functionally required for vessel pruning or is simply a consequence of it. Indeed, studies in zebrafish have shown that while EC apoptosis is associated with vessel pruning, it is largely dispensable for this process, with EC rearrangements being the primary driver of vessel pruning. 36, 37 Recent detailed analysis of the angiogenic retinal vasculature in mice found that only~5% of regressing vessels found during normal angiogenesis actually contained apoptotic ECs. 38 Whether EC apoptosis is functionally necessary for vessel pruning in the mouse retina is yet to be determined.
Of the pro-survival BCL2 proteins, only BCL2 itself has previously been investigated for its function in EC survival in vivo, where it was also implicated in EC survival during retina angiogenesis. 39 However, its role and regulation may be quite distinct to that of MCL1: whereas we found MCL1 was important for EC survival in the proliferative regions of the vasculature at P5, apoptosis in Bcl2 − / − retinas was reported at P14, 39 when very little EC proliferation is occurring. 9 It seems highly likely that pro-survival proteins will have distinct roles within in the vasculature to promote its survival and health. Our findings have clearly demonstrated that MCL1 has a 16 Bim mice, 40 Conditional Bax mice, 41 Bak null mice, 42 Cdh5(PAC)-creERT2 mice 18 and Tie2-cre mice 15 have all been described previously. Animals were maintained on an inbred C57BL/6 background. Noon on the day a vaginal mating plug was observed was termed E0.5. The day of birth was termed P0. Tamoxifen (50 μg/dose in sterile corn oil) was administered via intragastric injection to litters on P2 or P2 and P3.
Immunohistochemical analysis of whole mount embryonic dorsal skin vasculature. E14.5 embryo proper were fixed in 4% paraformaldehyde for 2 h at 4°C. Dorsal skin tissue was dissected and extra layers of tissue and muscle removed. Dorsal skin samples were washed through 25, 50, 75% and stored in 100% methanol at − 20°C at least overnight until further processing. Samples were washed through a reverse methanol series prior to staining with rabbit anti-collagen IV antibody (20 μg/ml, AB756P, Millipore, Kilsyth, VIC, Australia) and hamster anti-PECAM1 (5 μg/ml, clone 2H8, ab78739, Abcam, Cambridge, United Kingdom) in 2% normal donkey serum, 1% Triton X-100 in Dulbecco's phosphate buffered saline solution (DPBS) overnight at 4°C. Samples were washed (0.01%, Triton X-100 in DPBS) then incubated with secondary antibodies: Donkey anti-rabbit IgG DyLight 488 (711-485-152, Jackson ImmunoResearch, West Grove, PA, USA) and Goat anti-hamster IgG Alexa-Fluor 647 (127-605-160, Jackson ImmunoResearch) in blocking buffer overnight at 4°C. Samples were then washed before being mounted on slides in ProLong Gold antifade reagent (Invitrogen, Mulgrave, VIC, Australia) and imaged using a Leica SP8 (Leica, North Ryde, NSW, Australia) confocal microscope with a × 10/0.40 NA objective using Leica Application Suite software (Leica, North Ryde, NSW, Australia) or a Zeiss LSM 780 (Zeiss, North Ryde, NSW, Australia) confocal microscope with a × 10/0.45 NA objective using Zen software (Zeiss, North Ryde, NSW, Australia). Quantification of avascular space was performed using Adobe Photoshop for manual tracing of avascular area followed by quantification of area using FIJI distribution of ImageJ software (NIH, Bethesda, MD, USA) from confocal z-stack projections of dorsal skin vasculature. 43 Sprout length in dorsal skin vasculature was measured to the nearest branch point manually using FIJI distribution of ImageJ software on a 1500 μm length of sprouting front.
Immunohistochemical analysis of retinal vasculature. Eyes were enucleated and fixed in 4% paraformaldehyde for 2 h at 4°C. Retinas were then dissected, incubated in blocking buffer (2% normal donkey serum, 1% Triton X-100 in DPBS) then stained with rat anti-PECAM1 (5 μg/ml, clone MEC 13.3, 553370, BD Pharmingen), goat anti-collagen IV antibody (14 μg/ml, AB769, Millipore) and rabbit anti-cleaved (activated) caspase-3 antibody (used at 1/50, clone 5A1, 9664, Cell Signaling Technologies, Beverly, MA, USA) in blocking buffer overnight at 4°C. Retinas were washed (0.01% Triton X-100 in DPBS) then incubated with secondary antibodies: anti-rat IgG DyLight 488 (711-485-152, Jackson ImmunoResearch), antigoat IgG Alexa-Fluor 647 (705-605-147, Jackson ImmunoResearch) and anti-rabbit IgG Cy3 (711-165-152, Jackson ImmunoResearch) in blocking buffer overnight at 4°C. Retinas were then washed before being mounted on slides in ProLong Gold antifade reagent. All retina imaging was performed using a Leica SP8 confocal microscope with a × 20/0.75 NA objective using Leica Application Suite software. Apoptotic ECs were defined as cleaved caspase-3
+ cells enclosed by collagen IV in the x-, y-and z-axis from confocal z-stack images. Quantification of cleaved caspase-3-positive ECs was performed manually using FIJI distribution of ImageJ software from confocal z stacks of entire retinas. Classification of an EC as apoptotic required agreement by two investigators. Vessel surface area measurements of whole retinas were quantified using FIJI software based on the collagen IV signal in maximum intensity projection images generated from confocal z stacks of entire retinas. Vasculature at the optic nerve head and residual hyaloid vasculature were manually masked and excluded from vessel surface area quantification. Quantification was performed using the thresholding function and included removal of non-specific background using the despeckle filter. Quantification of vessel area in whole retinas using this method was verified using independent methodology in a semi-automated manner through a custom written FIJI macro, by an independent investigator who was blinded to genotype. The steps of the macro involved initial processing and filtering, specifically a maximum intensity projection of collagen IV signal and background subtraction, followed by manual outlining of optic nerve head and residual hyaloid vasculature to exclude these from the measurements. The macro then segmented the retina using the triangle method of automatic thresholding. Vessel segment density and branch point density were quantified across two fields of view/retina using the Angiogenesis Tube Formation module of Metamorph image processing software (version 7.8.2.0, Molecular Devices, Sunnyvale, CA, USA) on the collagen IV signal. Vessel regression was determined as a ratio of PECAM1 + vessel segment length to collagen IV + vessel segment length. Vessel regression analysis was performed as follows: binary masks of PECAM1 and collagen IV channels were produced through auto thresholding and the use of various image and morphological filters. A collagen IV + PECAM1 − vessel segment mask (regressing vessels) was generated by subtracting the PECAM1 channel mask from the collagen IV channel mask. Collagen IV + PECAM − vessel segment mask and the collagen IV channel mask were then skeletonized and their total vessel lengths measured. These steps were all implemented in a custom FIJI macro allowing for full automation of the data set. Data were compiled from two to three fields of view/retina from the remodeling vein region and four to six fields of view/retina from the sprouting region. Vessel regression analysis was undertaken by investigators who were blinded to genotype.
Flow cytometry analysis and sorting of ECs and blood cells. Whole E10.5 embryos were dissected free of extra-embryonic membranes. Yolk sac and embryo proper were separately digested in DPBS containing 0.25 WU/ml Liberase TM (Roche), 10 μg/ml DNase I (Roche, Dee Why, NSW, Australia) and 5 mM MgCl 2 for 40 min at 37°C with constant agitation. Dissociated cells were stained with anti-PECAM1-APC (clone MEC 13.3, 551262, BD Pharmingen, North Ryde, NSW, Australia) anti-ICAM2-FITC (clone 3C4(mIC2/4), 557444, BD Biosciences, North Ryde, NSW, Australia), anti-hCD4-PE (clone RPA-T4, 555347, BD Pharmingen) and anti-CD41-PEcy7 (MWReg30, 25-0411-82, eBiosciences, San Diego, CA, USA). Cells were analyzed using a BD LSR II flow cytometer (BD Bioscience) and ECs defined as PECAM1 Hi ICAM2 Hi CD41 − cells. Dead cells were excluded based on DAPI uptake. Tissues from neonates were digested as described above and passed through 50-μm filter mesh. Dissociated cells were stained using anti-PECAM1-APC (clone 390, 17-0311, eBiosciences), anti-ICAM2-FITC, anti-CD45.2-PerCPcy5.5 (clone 104, 561096, BD Pharmingen) and antihCD4-PE. ECs were defined as PECAM1 Hi ICAM2 Hi CD45
− . Dead cells were excluded based on DAPI uptake. For white blood cell analysis, bone marrow was flushed from one femur of each mouse with balanced salt solution containing 1% heat-inactivated fetal calf serum and dissociated by trituration using a 21G needle (BD, North Ryde, NSW, Australia). Dissociated cells were stained with anti-Ter119-APC (prepared in-house), anti-CD45.2-PerCPcy5.5 and anti-hCD4-PE. White blood cells were defined as Ter119 − CD45.2 + . Dead cells were excluded based on DAPI uptake. Flow cytometric analysis of adult mice was as described for neonates, but using anti-PECAM1-APC clone MEC 13.3 (BD Pharmingen). Adult kidney ECs for fluorescence-activated cell sorting sorting were prepared as described above for flow cytometric analysis and sorted using an Aria IIu sorter (BD bioscience). ECs were defined as PECAM1 Hi CD45
− . In some cases, anti-ICAM2-FITC (clone 3C4(mIC2/4), 557444, BD Biosciences) or anti-CD105-PE (MJ7/18, 12-1051, eBioscience) were used as additional EC markers. Dead cells were excluded based on DAPI uptake. For flow cytometric analysis, ECs were defined as PECAM1
Hi
ICAM2
Hi CD45
− . White blood cells from bone marrow were defined as Ter119 − CD45.2 + . Dead cells were excluded based on DAPI uptake. All flow cytometric analysis data were acquired using an LSR II flow cytometer and analyzed using FlowJo software. ECs were sorted using an Aria IIu sorter.
Genomic PCR analysis. Genomic PCR was performed on DNA extracted from sorted kidney ECs. The primers used were: Mcl1-5′: 5′-gcacaatccgtccgcgagccaa-3′, Mcl1-3′: 5′-gccgcagtacaggttcaag-3′ and Mcl1-del: 5′-gagtcagcgcgatcattcagct-3′. Expected product sizes were: 327 bp (WT allele), 409 bp (fl allele) and 567 bp (del allele).
Statistics. Statistical analysis was performed using one-way analysis of variance test with Tukey's multiple comparison test unless otherwise indicated. Two-tailed χ 2 -tests were used to analyze offspring frequency.
